4//SEC Filing
Lundbeckfond Invest A/S 4
Accession 0000899243-19-013250
CIK 0001563880other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:00 PM ET
Size
8.9 KB
Accession
0000899243-19-013250
Insider Transaction Report
Form 4
Lundbeckfond Invest A/S
10% Owner
Transactions
- Conversion
Series C Preferred Stock
2019-05-09−6,849,315→ 0 total→ Common Stock (776,544 underlying) - Conversion
Common Stock
2019-05-09+776,544→ 776,544 total - Purchase
Common Stock
2019-05-09$10.00/sh+375,000$3,750,000→ 1,151,544 total
Footnotes (1)
- [F1]On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
IncorporatedDenmark
Related Parties
1- filerCIK 0001591046
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:00 PM ET
- Size
- 8.9 KB